A Irinotecan Liposome Trial of in Advanced Neuroendocrine Carcinoma
Clinical trial NCT07014540 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07014540
- Sponsor
- Beijing GoBroad Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-20
- Primary completion
- 2026-12-31
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.